My watch list  

12 Current news about the topic target validation


You can refine your search further. Select from the filter options on the left to narrow down your results.

Lexicon Genetics Delivers Thirteen Novel Antigens To Abgenix For Antibody Development


Lexicon Genetics Incorporated (Nasdaq: LEXG) and Abgenix, Inc. (Nasdaq: ABGX) announced today that Lexicon has delivered to Abgenix, thirteen (13) human antigens for antibody development as part of the companies’ drug discovery alliance. This marks the first of many antigens to be delivered to ...


Athersys To Provide Bristol-Myers Squibb With Validated Drug Targets


Athersys Inc. today announced that it has entered into a collaboration with Bristol-Myers Squibb Company (NYSE: BMY) in which Athersys will provide Bristol-Myers Squibb access to its proprietary RAGE-VT™ (Random Activation of Gene Expression for Validated Targets) technology for the ...


Page 2 From 2
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE